🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Dilation Capital Management - Q4 2025 13F Filings

DI

Dilation Capital Management Lp

CIK: 0001922880
Address: New York New York 767 Fifth Avenue 18Th Floor
$217.44 M
Portfolio Value
19
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 10/13/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Sells

Q4 2025

Asset Allocation

Stocks/ETFs
+7.77%
$217.44 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Dilation Capital Management Q4 2025 Filing Summary

Dilation Capital Management Lp filed its 13F report for Q4 2025 on February 09, 2026. The portfolio totaled 217.44 M reflecting a +7.77% change from the prior quarter, spanning 19 assets. The top 10 holdings comprised 73.2% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 2 new positions and 4 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Dilation Capital Management’s Q4 2025 Filing

Dilation Capital Management submitted their Form 13F-HR for the Q4 2025 period on 02/09/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Dilation Capital Management reported a managed portfolio value of 217.44 M, consisting of 19 individual positions.

This page displays the raw filing documents. To see which stocks Dilation Capital Management bought or sold during Q4 2025, please visit Dilation Capital Management's Portfolio Analysis page.